Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
Allergol. immunopatol ; 45(6): 602-615, nov.-dic. 2017. tab, graf
Artículo en Inglés | IBECS | ID: ibc-168469

RESUMEN

Common variable immunodeficiency (CVID) is a diagnostic category of primary immunodeficiency (PID) which may present with heterogeneous disorders including recurrent infections, autoimmunity, granulomatous diseases, lymphoid and other types of malignancies. Generally, the incidence of malignancy in CVID patients is around 1.5-20.7% and usually occurs during the 4th-6th decade of life. Non-Hodgkin lymphoma is the most frequent malignancy, followed by epithelial tumours of stomach, breast, bladder and cervix. The exact pathological mechanisms for cancer development in CVID are not fully determined; however, several mechanisms including impaired genetic stability, genetic predisposition, immune dysregulation, impaired clearance of oncogenic viruses and bacterial infections, and iatrogenic causes have been proposed to contribute to the high susceptibility of these patients to malignancies (AU)


No disponible


Asunto(s)
Humanos , Inmunodeficiencia Variable Común/epidemiología , Linfoma/epidemiología , Neoplasias/epidemiología , Inmunodeficiencia Variable Común/fisiopatología , Comorbilidad , Enfermedades Autoinmunes/epidemiología , Susceptibilidad a Enfermedades , Factores de Riesgo , Infecciones/complicaciones
2.
Allergol Immunopathol (Madr) ; 45(6): 602-615, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28411962

RESUMEN

Common variable immunodeficiency (CVID) is a diagnostic category of primary immunodeficiency (PID) which may present with heterogeneous disorders including recurrent infections, autoimmunity, granulomatous diseases, lymphoid and other types of malignancies. Generally, the incidence of malignancy in CVID patients is around 1.5-20.7% and usually occurs during the 4th-6th decade of life. Non-Hodgkin lymphoma is the most frequent malignancy, followed by epithelial tumours of stomach, breast, bladder and cervix. The exact pathological mechanisms for cancer development in CVID are not fully determined; however, several mechanisms including impaired genetic stability, genetic predisposition, immune dysregulation, impaired clearance of oncogenic viruses and bacterial infections, and iatrogenic causes have been proposed to contribute to the high susceptibility of these patients to malignancies.


Asunto(s)
Inmunodeficiencia Variable Común/epidemiología , Sistema Inmunológico , Neoplasias/epidemiología , Factores de Edad , Inmunodeficiencia Variable Común/complicaciones , Inmunodeficiencia Variable Común/fisiopatología , Interacción Gen-Ambiente , Predisposición Genética a la Enfermedad , Homeostasis , Humanos , Incidencia , Neoplasias/complicaciones , Neoplasias/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA